BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6100289)

  • 1. Etiology of hepatocellular carcinoma in Africa.
    Olweny CL
    IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does hepatitis B virus cause hepatocellular carcinoma?
    Trichopoulos D; Kremastinou J; Tzonou A
    IARC Sci Publ; 1982; (39):317-32. PubMed ID: 6295934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M; Ashcavai M; Liew CT; Peters RL
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC; Yuan JM; Ross RK; Govindarajan S
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus chronic liver disease and hepatocellular carcinoma.
    Zuckerman AJ; Harrison TJ
    Postgrad Med J; 1987; 63 Suppl 2(737):13-9. PubMed ID: 2825153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of hepatocellular carcinoma].
    Ricca Rosellini S; Miglio F
    Minerva Gastroenterol Dietol; 1991; 37(2):73-84. PubMed ID: 1660311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions.
    Bosch FX; Muñoz N
    IARC Sci Publ; 1988; (89):427-38. PubMed ID: 2848766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between hepatocellular carcinoma and persistent hepatitis B infection.
    Popper H
    Appl Pathol; 1988; 6(2):64-72. PubMed ID: 2839217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.